A former Gary Glick biotech, now a penny stock, will lay off staff and close offices after PhII fail
May 2, 2022, 4:02 pm
The Santa Monica, CA-based biotech’s stock shot up early Friday on reports that it had agreed to a licensing deal with Hikma Pharmaceuticals on an experimental nasal spray to treat opioid overdoses.
